NEW YORK (GenomeWeb) – St. Jude Children's Research Hospital has appointed James Downing as its new CEO, effective July 15. Downing most recently served as deputy director, executive vice president, and scientific director of the hospital. He will succeed William Evans, who is retiring as CEO after 10 years and returning full time to his pharmacogenomics research program at St. Jude.


EpiCypher, an epigenomics products and services firm, has named Sam Tetlow to be its first CEO and to serve on the board of directors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.